|
|
 |
 |
| Max India Overview |
Founded in 1985, Max India Ltd. is a Public Limited company listed on the NSE and BSE of India with over 30,000 shareholders. Max India Limited is a multi-business corporate entity driven by the spirit of enterprise with a focus on people and service oriented businesses.
Prominent shareholders of the company are Mr Analjit Singh and a leading private equity firm, Warburg Pincus. The balance shareholding is held by the public and Institutional Investors.
The company´s vision is "to be one of India´s most admired corporates for Service Excellence." Towards this end, it has established businesses that are today recognized as being at the fore front of service excellence, in each of the industry sectors where it operates. Performance, Trust and Service Excellence are enshrined in Max India Group´s Vision, Mission and Values.
Max India Group Mission
 |
Establish niche service businesses in Life Insurance, Healthcare and clinical research |
|
Life Insurance and Healthcare convergence |
|
Rank amongst top three players in each niche |
|
Partner with best-in-class world leaders |
|
Create trust and service excellence in all Business |
 |
Protecting Life through its life insurance subsidiary Max New York Life, a joint venture between Max India and New York Life, a Fortune 100 company |
|
|
Caring for Life through its healthcare company, Max Healthcare Institute Limited, a subsidiary of Max India Limited |
|
|
Enhancing Life through its health insurance company, Max Bupa Health Insurance, a joint venture between Max India and Bupa Finance Plc., UK which is set to launch after statutory approvals |
|
|
Improving Life through its clinical research business, Max Neeman, a fully owned subsidiary of Max India. |
|
|
Create trust and service excellence in all Business |
In addition to these "life-centred" businesses, Max India manufactures speciality products for the packaging industry through its division - Max Speciality Products. MSP too, has a strong service excellence orientation that strives on building long lasting partnerships with marquee customers.
|
| |
  Max India Group Key Milestones as on 31st March 2009.
|
Max India Group crosses USD 1 billion mark in revenue |
|
Consolidated Revenue CAGR of 57% in 3 years, marking impressive performance. |
|
The total investment in various businesses of Rs. 1,800 Crore triples to Market Valuation of Rs. 5,000 Crore |
|
The Group has over 581 offices across more than 382 locations in the Country and with people strength of 100,000+ persons |
|
The total consumer base increased from 2.5 million in 2007-08 to 3.5 million in 2008-09. |
|
| |
| Details of subsidiaries |
| |
Max New York Life Insurance Company
|
| |
Max Healthcare
MHC is the country´s first comprehensive provider of standardized, seamless and world-class healthcare services. It is committed to the highest standards of medical and service excellence, patient care, scientific and medical education. MHC operates eight centers in Delhi & NCR, offering services in over 30 medical disciplines. MHC has state of the art tertiary care facilities at Saket in South Delhi, secondary care hospitals at Pitampura, Patparganj, Gurgaon and Noida and an out patient facility, the Max Medcentre and a Speciality centre focused on Eye and Dental care at Panchsheel Park.
The tertiary care hospitals at Saket include Max Devki Devi Heart & Vascular Institute, a Centre of Excellence in cardiac services and the Max Super Speciality Hospital, a super speciality facility in Orthopaedics & Joint Replacement, Neurosciences, Paediatrics, Obstetrics & Gynaecology, Aesthetic & Reconstructive Plastic Surgery and Internal Medicine. In addition, it has an Institute of Allied Medical Services where it provides General and Laparoscopic surgery, Urology, Eye & ENT, Nephrology, Dermatology, Department of Mental Health & Behavioural Sciences amongst others. MHC has collaboration with Singapore General Hospital in the areas of medical practices, nursing, paramedical, research and training.
Key Highlights as on March 31, 09
|
Revenue across network of hospitals: Rs 423 crore over 373 crore last year, registering a 13% growth |
|
1200 Physicians, 1600 Nurses, 370 Paramedics, 1150 Support Staff. |
|
Patient Satisfaction scores over 90% |
|
| |
Max Neeman
MNMI is a Clinical Research services provider offering services across the value chain of new drug development to a growing list of Pharmaceutical, Biotech and Clinical Research clients, in India and abroad. MNMI continues to focus on developing alliances with mid sized pharma and biotech companies to transition their drug development work to India. It has an employee base of 200 and five Regional offices in India & one business development office in USA.
Key Highlights as on March 31, 09
|
Although at an early stage of development, has enrolled over 5,800 patient subjects across 200 sites since its inception |
|
Patient retention rate — a critical business driver in clinical trials — is 98% against an industry average of 65% to 70% |
|
| |
Max Speciality Products
|
| |
Max Bupa Health Insurance Limited (MBHI),
Max Bupa Health Insurance Limited (MBHI),a joint venture between Max India and UK-based Bupa Group. It is on course to start operations in the next 12 months. The Company has put in place its top management team headed by its CEO, Dr. Damien Marmion.
|
|
|
 |
 |
|
 |
Max Super Speciality Hospital |
|
|
International Patient Services |
|
|
The Max Hospital Network |
|
|
 |
|
 |
Download brochure |
|
|
 |
|
 |
|
 |
Analjit Singh,
Founder & Chairman, Max India
There´s a lot more to India´s leading entrepreneur and philanthropist.
|
|
Download brochure |
|
|
|
|
